◀ Anchor ▶
Yesterday, at a debate, a study was announced that Namyang Dairy’s Bulgaris has the effect of suppressing Corona 19. Shortly after that, the company’s stock price soared and Bulgaris ran out of marts.
However, it turned out that it was not an experiment for humans, and it was confirmed that Namyang Dairy paid the money for both the experiment and the debate that announced this.
Reporter Oh Hae-jeong covered it.
◀ Report ▶
Symposium on antiviral food development in the corona era.
It was packaged as if it had been researched on several foods, but only one food appeared.
This is Namyang Dairy’s Bulgari.
Presenters claim that the vulgaris reduced the flu virus by 99.999% and the corona 19 virus by 77.78%.
In the meantime, I secretly recommend the Bulgaris.
[김경순/한국의과학연구원 마이크로바이옴 센터장]
“If the same food is evaluated under the same conditions, if it is more favorable to the virus, isn’t it time for us to choose that way?”
However, if you look closely, it is not a clinical trial for humans.
In the laboratory, we experimented with cells of monkeys and dogs.
As a result of the interview, it was Namyang Dairy that paid for this research.
The forum was also borrowed from Namyang Dairy.
Namyang Dairy, based on this self-study, promoted the Bulgari to a large extent.
Several media outlets used this study as it was, and Bulgaris was sold out at internet shopping malls and marts.
In yesterday’s stock market, Namyang Dairy’s stock price soared 8% just 30 minutes before the close of the market, and this morning it hit the ceiling.
Experts immediately objected to this study.
[정재훈/가천의대 예방의학과 교수]
“The important thing is whether there is an effect when it enters the human body or not. It is not an effect in the laboratory. It can be a great risk for quarantine to be presented in the form of a presentation without peer (researcher) verification.”
The Food Labeling and Advertising Act prohibits advertising in the form of food preventing disease.
The Ministry of Food and Drug Safety said it is reviewing whether Namyang Dairy is illegal.
Financial authorities are also watching.
If you don’t properly inform you that there were no clinical trials for the purpose of making money, you may be a fraudulent transaction under the Capital Markets Act.
In fact, looking at the share price of Namyang Dairy, I started to wriggle four days before the announcement.
It is possible that someone has used nonpublic information.
Namyang Dairy’s stock price, which hit the ceiling this morning, plunged again, falling more than 5% from yesterday.
This is Haejeong Oh, MBC News.
(Video editing: Dongwon Wi)
MBC News awaits your report 24 hours a day.
▷ Phone 02-784-4000
▷ Email [email protected]
▷ KakaoTalk @mbc report